Related references
Note: Only part of the references are listed.Preoperative Radiosurgery for Resected Brain Metastases: The PROPS-BM Multicenter Cohort Study
Roshan S. Prabhu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study
Hussein A. Tawbi et al.
LANCET ONCOLOGY (2021)
Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases
Giuseppe Minniti et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Nodular Leptomeningeal Disease-A Distinct Pattern of Recurrence After Postresection Stereotactic Radiosurgery for Brain Metastases: A Multi-institutional Study of Interobserver Reliability
Brandon E. Turner et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
Teresa Amaral et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Hemorrhagic and Cystic Brain Metastases Are Associated With an Increased Risk of Leptomeningeal Dissemination After Surgical Resection and Adjuvant Stereotactic Radiosurgery
Robert H. Press et al.
NEUROSURGERY (2019)
A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases
Roshan S. Prabhu et al.
NEURO-ONCOLOGY (2019)
Association of Neurosurgical Resection With Development of Pachymeningeal Seeding in Patients With Brain Metastases
Daniel N. Cagney et al.
JAMA ONCOLOGY (2019)
Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery
Rosaline Ma et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Postoperative radiosurgery for the treatment of metastatic brain tumor: Evaluation of local failure and leptomeningeal disease
Paul M. Foreman et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2018)
Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial
Takamasa Kayama et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Hussein A. Tawbi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Leptomeningeal metastasis from systemic cancer: Review and update on management
Nancy Wang et al.
CANCER (2018)
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3): a multicentre, randomised, controlled, phase 3 trial
Paul D. Brown et al.
LANCET ONCOLOGY (2017)
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial
Anita Mahajan et al.
LANCET ONCOLOGY (2017)
Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis
Nayan Lamba et al.
RADIATION ONCOLOGY (2017)
Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery
Matthew D. Johnson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
Sarah B. Goldberg et al.
LANCET ONCOLOGY (2016)
Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis
Kirtesh R. Patel et al.
NEUROSURGERY (2016)
Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery
Andrew J. Huang et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis
Eric Ojerholm et al.
JOURNAL OF NEUROSURGERY (2014)
Risk of Leptomeningeal Disease in Patients Treated With Stereotactic Radiosurgery Targeting the Postoperative Resection Cavity for Brain Metastases
Banu Atalar et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Epidemiology of Brain Metastases
Lakshmi Nayak et al.
CURRENT ONCOLOGY REPORTS (2012)
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
Martin Kocher et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
COMPARATIVE RISK OF LEPTOMENINGEAL DISSEMINATION OF CANCER AFTER SURGERY OR STEREOTACTIC RADIOSURGERY FOR A SINGLE SUPRATENTORIAL SOLID TUMOR METASTASIS
Dima Suki et al.
NEUROSURGERY (2009)
Boost radiosurgery for treatment of brain metastases after surgical resections
Yoshiyasu Iwai et al.
SURGICAL NEUROLOGY (2008)
Share Paper
